Work

Blinatumomab Alternating With Low-Intensity Chemotherapy (CT) Treatment for Older Adults With Newly Diagnosed Philadelphia (Ph)-Negative B-Cell Precursor Acute Lymphoblastic Leukemia (BCP-ALL) is Well Tolerated and Efficacious: Safety Run-In Results for the Phase 3 Randomized Controlled Golden Gate Study

Year: 2022

Type: article

Source: Blood

DOI: 10.1182/blood-2022-156080

Authors: Elias Jabbour, Ibrahim Aldoss, Shaun Fleming, Ashish Bajel, Paul Cannell, Monika Brüggemann, Gerhard Zugmaier, Joan Morris, Yuqi Chen, Sonny Powar, Hansen Wong, Björn Steffen, Hagop Kantarjian, Nicola Goekbuget

Institutions: The University of Texas MD Anderson Cancer Center, City Of Hope National Medical Center, The Alfred Hospital, The Royal Melbourne Hospital, Peter MacCallum Cancer Centre, Fiona Stanley Hospital, University Hospital Schleswig-Holstein, Amgen (Germany), Amgen (United States), Amgen (United Kingdom), University Hospital Frankfurt, Goethe University Frankfurt

Language: English

Topic: Acute Lymphoblastic Leukemia research

Subfield: Public Health, Environmental and Occupational Health

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W4310119332

FWCI: 4.644

Cites:

Cited by: 23

Related to: 10